LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Rechallenge in advanced GIST progressing to imatinib, sunitinib and regorafenib: An Italian survey.

Photo by nci from unsplash

11038Background: We retrospectively collected data from metastatic Italian GIST patients treated with imatinib or sunitinib reintroduction after progression to conventional three or four lines of t... Click to show full abstract

11038Background: We retrospectively collected data from metastatic Italian GIST patients treated with imatinib or sunitinib reintroduction after progression to conventional three or four lines of t...

Keywords: sunitinib regorafenib; imatinib sunitinib; advanced gist; gist progressing; progressing imatinib; rechallenge advanced

Journal Title: Journal of Clinical Oncology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.